A detailed history of Assetmark, Inc transactions in Insulet Corp stock. As of the latest transaction made, Assetmark, Inc holds 17 shares of PODD stock, worth $4,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Holding current value
$4,422
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$180.69 - $239.01 $3,071 - $4,063
17 New
17 $3,000
Q4 2023

Feb 09, 2024

BUY
$127.77 - $221.42 $54,557 - $94,546
427 Added 9.97%
4,711 $1.02 Million
Q3 2023

Oct 27, 2023

SELL
$154.67 - $290.89 $143,688 - $270,236
-929 Reduced 17.82%
4,284 $683,000
Q2 2023

Aug 11, 2023

BUY
$272.48 - $330.23 $103,542 - $125,487
380 Added 7.86%
5,213 $1.5 Million
Q1 2023

May 05, 2023

BUY
$276.36 - $326.03 $41,454 - $48,904
150 Added 3.2%
4,833 $1.54 Million
Q4 2022

Feb 10, 2023

BUY
$212.22 - $313.46 $51,357 - $75,857
242 Added 5.45%
4,683 $1.38 Million
Q3 2022

Nov 01, 2022

BUY
$224.6 - $281.45 $481,767 - $603,710
2,145 Added 93.42%
4,441 $1.02 Million
Q2 2022

Aug 03, 2022

BUY
$186.4 - $279.02 $18,267 - $27,343
98 Added 4.46%
2,296 $500,000
Q1 2022

May 13, 2022

BUY
$194.8 - $275.7 $224,409 - $317,606
1,152 Added 110.13%
2,198 $586,000
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $256,085 - $319,244
1,003 Added 2332.56%
1,046 $278,000
Q3 2021

Nov 12, 2021

BUY
$260.36 - $307.27 $11,195 - $13,212
43 New
43 $12,000
Q2 2020

Aug 11, 2020

SELL
$159.17 - $224.73 $999,269 - $1.41 Million
-6,278 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$130.01 - $216.44 $816,202 - $1.36 Million
6,278 New
6,278 $1.04 Million
Q3 2019

Nov 13, 2019

SELL
$117.35 - $167.95 $28,281 - $40,475
-241 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$72.44 - $101.87 $17,458 - $24,550
241 New
241 $23,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.